UBS Group’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $10.4M | Sell |
|
|||||
|
2025
Q2 | $7.75M | Sell |
|
|||||
|
2025
Q1 | $10.1M | Sell |
|
|||||
|
2024
Q4 | $16.5M | Buy |
|
|||||
|
2024
Q3 | $7.96M | Buy |
|
|||||
|
2024
Q2 | $3.29M | Buy |
|
|||||
|
2024
Q1 | $229K | Buy |
|
|||||
|
2023
Q4 | $160K | Sell |
|
|||||
|
2023
Q3 | $118K | Sell |
|
|||||
|
2023
Q2 | $221K | Buy |
|
|||||
|
2023
Q1 | $97.7K | Buy |
|
|||||
|
2022
Q4 | $20.9K | Sell |
|
|||||
|
2022
Q3 | $60K | Buy |
|
|||||
|
2022
Q2 | $7K | Sell |
|
|||||
|
2022
Q1 | $23K | Sell |
|
|||||
|
2021
Q4 | $67K | Sell |
|
|||||
|
2021
Q3 | $122K | Sell |
|
|||||
|
2021
Q2 | $91K | Buy |
|
|||||
|
2021
Q1 | $63K | Buy |
|
|||||
|
2020
Q4 | $32K | Buy |
|
|||||
|
2020
Q3 | $20K | Sell |
|
|||||
|
2020
Q2 | $38K | Buy |
|
|||||
|
2020
Q1 | $26K | Sell |
|
|||||
|
2019
Q4 | $54K | Buy |
|
|||||
|
2019
Q3 | $18K | Buy |
|
|||||
|
2019
Q2 | $6K | Buy |
|
|||||
|
2019
Q1 | $0 | Sell |
|
|||||
|
2018
Q4 | $8K | Sell |
|
|||||
|
2018
Q3 | $26K | Buy |
|
|||||
|
2018
Q2 | $29K | Buy |
|
|||||
|
2018
Q1 | $8K | Sell |
|
|||||
|
2017
Q4 | $16K | Buy |
|
|||||
|
2017
Q3 | $1K | Sell |
|
|||||
|
2017
Q2 | $28K | Buy |
|
|||||
|
2017
Q1 | $2K | Sell |
|
|||||
|
2016
Q4 | $35K | Buy |
|
|||||
|
2016
Q3 | $23K | Sell |
|
|||||
|
2016
Q2 | $38K | Buy |
|
|||||
|
2016
Q1 | $19K | Buy |
|
|||||
|
2015
Q4 | $0 | Sell |
|
|||||
|
2015
Q3 | $12K | Sell |
|
|||||
|
2015
Q2 | $930K | Buy |
|
|||||
|
2015
Q1 | $614K | Sell |
|
|||||
|
2014
Q4 | $757K | Buy |
|